FindTrial
Sign In

Effect of Dilatation and Curettage on the Endometrial Receptivity

Effect of Dilatation and Curettage on the Endometrial Receptivity and Pregnancy Outcome in Patients With Recurrent Implantation Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03485235
Enrollment
160
Registered
2018-04-02
Start date
2018-03-31
Completion date
2019-12-10
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embryo Implantation

Brief summary

Effect of dilatation and curettage on the endometrial receptivity and pregnancy outcome in patients with recurrent implantation failure

Interventions

PROCEDURED&C

Dilatation and curettage

PROCEDUREICSI

Intra Cytoplasmic Sperm Injection

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

1. All the patients had at least 3 failed trials of IVF-ET with day 5 fresh blastocyst transferred 2. At least 10 high-grade embryos were obtained in the previous trials 3. Level of AMH more than or equal 1.1 ng/ml. 4. Age: Less than or equal to 35 years

Exclusion criteria

1. Patients with uterine pathology e.g. myoma , Asherman syndrome, Septum ,adenomyosis 2. Hydrosalpinx 3. Endometriosis 4. patients with diagnosed autoimmune diseases affecting pregnancy e.g. S.L.E.

Design outcomes

Primary

MeasureTime frame
Live Birth Rate9 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026